These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 20697836
1. Intensive versus conventional insulin therapy in critically ill neurologic patients. Green DM, O'Phelan KH, Bassin SL, Chang CW, Stern TS, Asai SM. Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836 [Abstract] [Full Text] [Related]
2. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes. Graffagnino C, Gurram AR, Kolls B, Olson DM. Neurocrit Care; 2010 Dec; 13(3):307-12. PubMed ID: 21086066 [Abstract] [Full Text] [Related]
6. Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot. Frontera JA. Neurocrit Care; 2010 Dec; 13(3):295-8. PubMed ID: 20972647 [No Abstract] [Full Text] [Related]
7. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols]. Raurell Torredà M, del Llano Serrano C, Almirall Solsona D, Catalan Ibars RM, Nicolás Arfelis JM. Med Clin (Barc); 2014 Mar 04; 142(5):192-9. PubMed ID: 23490488 [Abstract] [Full Text] [Related]
8. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study. Galiatsatos P, Gibson BR, Rabiee A, Carlson O, Egan JM, Shannon RP, Andersen DK, Elahi D. Crit Care Med; 2014 Mar 04; 42(3):638-45. PubMed ID: 24247476 [Abstract] [Full Text] [Related]
9. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. Coester A, Neumann CR, Schmidt MI. J Trauma; 2010 Apr 04; 68(4):904-11. PubMed ID: 20032790 [Abstract] [Full Text] [Related]
10. Glucose control in the intensive care unit. Fahy BG, Sheehy AM, Coursin DB. Crit Care Med; 2009 May 04; 37(5):1769-76. PubMed ID: 19325461 [Abstract] [Full Text] [Related]
11. Intensive versus conventional glucose control in critically ill patients. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. N Engl J Med; 2009 Mar 26; 360(13):1283-97. PubMed ID: 19318384 [Abstract] [Full Text] [Related]
12. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. Staszewski J, Brodacki B, Kotowicz J, Stepien A. J Stroke Cerebrovasc Dis; 2011 Mar 26; 20(2):150-4. PubMed ID: 20621520 [Abstract] [Full Text] [Related]
13. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G. J Clin Endocrinol Metab; 2007 Oct 26; 92(10):3890-7. PubMed ID: 17666481 [Abstract] [Full Text] [Related]
14. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis. Shan L, Hao PP, Chen YG. J Trauma; 2011 Nov 26; 71(5):1460-4. PubMed ID: 22071938 [Abstract] [Full Text] [Related]
16. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Grey NJ, Perdrizet GA. Endocr Pract; 2004 Nov 26; 10 Suppl 2():46-52. PubMed ID: 15251640 [Abstract] [Full Text] [Related]
17. Treating hyperglycemia in neurocritical patients: benefits and perils. Godoy DA, Di Napoli M, Rabinstein AA. Neurocrit Care; 2010 Dec 26; 13(3):425-38. PubMed ID: 20652767 [Abstract] [Full Text] [Related]